Tianjin Tianyao Pharmaceuticals Co., Ltd. (600488.SS) SHH

Currency In CNY

AD

Valuation

Market Cap4.44B
Enterprise Value4.32B
P/E Ratio115.19
PEG Ratio0.65
Price/Sales Ratio2.12
Price/Book Ratio1.78
Enterprise/Revenue2.15
Enterprise/EBITDA22.78

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterSeptember 30, 2026

Profitability

Profit Margin0.02
Operating Margin0.03
AD

Management Effectiveness

Return On Assets0.01
Return On Equity0.02

Income Statement

Revenue2.91B
Revenue/Share2.33
Gross Profit1.19B
EBITDA438.29M
Net Income70.56M
Diluted EPS0.07

Balance Sheet

Total Cash719.01M
Total Cash/Share0.66
Total Debt799.64M
Total Debt/Equity0.26
Current Ratio1.41
Book Value Per Share3.53

Price History

52-Week Change11.29
52-Week High8.44
52-Week Low3.68
Moving Average 50 Days5.67
Moving Average 200 Days5.39

Statistics

Average Volume81.18M
Shares Outstanding1.09B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.05
Trailing Annual Dividend Yield1.05
Payout Ratio2.6
Last Split Factor3:2
Last Split DateMarch 13, 2013
AD